¡Ya estamos en !
Descubre más
BLPH
Bellerophon Therapeutics, Inc.
Excluida de cotización
BLPH dejó de cotizar en bolsa el 13 de octubre de 2023.
Acerca de: Bellerophon Therapeutics Inc is a clinical-stage therapeutics company. The firm develops innovative products combining novel drugs and devices to treat cardiopulmonary diseases. It develops products under its INOpulse platform, which is an extension of the technology that is used in hospitals to deliver continuous-flow inhaled nitric oxide. The company's products are aimed at the treatment of different kinds of pulmonary hypertension.
Empleados: 18
Noticias
Positivo
Neutral
Negativo
Sentimiento
3 meses
Positivo
0%
Neutral
0%
Negativo
0%
No hemos recibido artículos de noticias recientes sobre BLPH.
Gráficos de precios implementados con Lightweight Charts™